Batchimeg Usukhbayar
MSc, PhD (TMM)
Biobanking Lead
I was qualified at the Health Sciences University of Mongolia and followed up with some research fellowships abroad. Since moving to the UK, I started working at the Department of Medical Oncology, Oxford University since 2007. Later I joined Professor Vyas' group to oversee the expanding Haematopoietic cell Biobank, which was central to the research programme in the Vyas Lab and subsequently joined Therapy Acceleration Laboratory.
Recent publications
-
Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging.
Jakobsen NA. et al, (2024), Cell Stem Cell, 31, 1127 - 1144.e17
-
Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.
Juban G. et al, (2021), Haematologica, 106, 1106 - 1119
-
Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome.
Cruz Hernandez D. et al, (2020), Blood, 136, 1460 - 1465
-
Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells.
Karamitros D. et al, (2018), Nat Immunol, 19, 85 - 97
-
Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.
Mettananda S. et al, (2017), Nat Commun, 8